Severe systemic cryptococcal disease in a child: review of prognostic indicators predicting treatment failure and an approach to maintenance therapy with oral fluconazole.
Moncino
M D
MD
Division of Hematology-Oncology, Duke University Medical Center, Durham, NC 27710.
Gutman
L T
LT
D000284:Administration, Oral; D000666:Amphotericin B / Q000627:therapeutic use; D002648:Child; D003453:Cryptococcosis / Q000150:complications / Q000188:drug therapy*; D005260:Female; D015725:Fluconazole / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications*; D011379:Prognosis; D012008:Recurrence
D000666:Amphotericin B; D015725:Fluconazole